These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22184911)
21. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures]. Ozcan SK; Mutlu B; Dündar D; Willke A Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961 [TBL] [Abstract][Full Text] [Related]
23. In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans. Mahboubi M; Ghazian Bidgoli F Phytomedicine; 2010 Aug; 17(10):771-4. PubMed ID: 20189786 [TBL] [Abstract][Full Text] [Related]
24. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. Wei GX; Xu X; Wu CD Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of essential oils extracted from condiments against fluconazole-resistant and -sensitive Candida glabrata. Soares IH; Loreto ÉS; Rossato L; Mario DN; Venturini TP; Baldissera F; Santurio JM; Alves SH J Mycol Med; 2015 Sep; 25(3):213-7. PubMed ID: 26281965 [TBL] [Abstract][Full Text] [Related]
26. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. Hammer KA; Carson CF; Riley TV J Antimicrob Chemother; 1998 Nov; 42(5):591-5. PubMed ID: 9848442 [TBL] [Abstract][Full Text] [Related]
27. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing. Buchta V; Vejsova M; Vale-Silva LA Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method. Madhavan P; Jamal F; Chong PP; Ng KP Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716 [TBL] [Abstract][Full Text] [Related]
29. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum. Khan MS; Ahmad I Appl Microbiol Biotechnol; 2011 May; 90(3):1083-94. PubMed ID: 21336686 [TBL] [Abstract][Full Text] [Related]
30. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606 [TBL] [Abstract][Full Text] [Related]
31. Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents? Bona E; Cantamessa S; Pavan M; Novello G; Massa N; Rocchetti A; Berta G; Gamalero E J Appl Microbiol; 2016 Dec; 121(6):1530-1545. PubMed ID: 27568869 [TBL] [Abstract][Full Text] [Related]
32. Susceptibility characterisation of Candida spp. to four essential oils. Rath CC; Mohapatra S Indian J Med Microbiol; 2015 Feb; 33 Suppl():93-6. PubMed ID: 25657164 [TBL] [Abstract][Full Text] [Related]
33. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039 [TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. Fleck R; Dietz A; Hof H J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369 [TBL] [Abstract][Full Text] [Related]
35. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468 [TBL] [Abstract][Full Text] [Related]
36. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064 [TBL] [Abstract][Full Text] [Related]
37. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients]. Kurnatowska AK; Kwaśniewska J Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility]. Cantón E; Pemán J; Sastre M; Valentín A; Bosch M; Espinel-Ingroff A Rev Esp Quimioter; 2006 Sep; 19(3):267-74. PubMed ID: 17099795 [TBL] [Abstract][Full Text] [Related]
39. Antifungal activities of Ocimum sanctum essential oil and its lead molecules. Khan A; Ahmad A; Manzoor N; Khan LA Nat Prod Commun; 2010 Feb; 5(2):345-9. PubMed ID: 20334156 [TBL] [Abstract][Full Text] [Related]
40. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. Tan GL; Peterson EM J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]